Embryo implantation and development requires the endometrial stromal cells (ESCs) to undergo decidualization. This differentiation process requires glucose utilization, and blockade of the pentose phosphate pathway inhibits decidualization of ESCs both in vitro and in vivo. Glucose and fatty acids are energy substrates for many cell types, and fatty acid beta-oxidation is critical for embryo implantation. Here, we investigated whether beta-oxidation is required for decidualization of ESCs. As assessed by marker gene expression, decidualization of human primary ESCs was blocked by reducing activity of carnitine calmitoyltransferase I, the rate-limiting enzyme in beta-oxidation, either by short hairpin RNA-mediated silencing or by treatment with the inhibitor etomoxir. Ranolazine (RAN), a partial beta-oxidation inhibitor, blocked early decidualization of a human ESC line. However, decidualization resumed after several days, most likely due to a compensatory up-regulation of GLUT1 expression and an increase in glucose metabolism. Simultaneous inhibition of the beta-oxidation pathway with RAN and the pentose phosphate pathway with glucosamine (GlcN) impaired in vitro decidualization of human ESCs more strongly than inhibition of either pathway alone. These findings were confirmed in murine ESCs in vitro, and exposure to RAN plus GlcN inhibited decidualization in vivo in a deciduoma model. Finally, intrauterine implantation of time-release RAN and GlcN pellets reduced pup number. Importantly, pup number returned to normal after the end of the pellet-active period. This work indicates that both fatty acids and glucose metabolism pathways are important for ESC decidualization, and suggests novel pathways to target for the design of future nonhormonal contraceptives.
INTRODUCTION
Establishment of a successful pregnancy requires a complex sequence of events. One key process is decidualization, in which endometrial stromal cells (ESCs) differentiate into decidual cells that coordinate embryo implantation and placental formation [1, 2] . This transformation is controlled by the hormones estrogen (E 2 ) and progesterone (P 4 ), and is most likely energy intensive [3, 4] . Several studies have confirmed that glucose metabolism is important for endometrial preparation and decidualization [4] [5] [6] . The efficiency of glucose uptake is determined by expression of facilitative glucose transporters (GLUTs); GLUT1 is the most abundant GLUT in ESCs, and its expression increases upon P 4 exposure [4] . Furthermore, glucose utilization via the pentose phosphate pathway (PPP) has been reported to be critical in the decidualization process [5, 7] . For example, competitive inhibition of the rate-limiting enzyme of the PPP, glucose 6-phosphate dehydrogenase (Fig. 1) , with the amino sugar glucosamine (GlcN), resulted in dramatically reduced decidualization both in vitro and in vivo [8] .
In addition to glucose, many cell types rely on fatty acids as a source of energy. The fatty acid b-oxidation pathway is an evolutionarily well-conserved process of metabolizing fatty acids within the mitochondria to generate acetyl-coA and ATP. Initially, activated fatty acids with long-chain acyl-CoA are transported across the outer mitochondrial membrane by carnitine palmitoyl transferase 1 (CPT1), the rate-limiting step in b-oxidation, with the conversion of the long-chain acyl-CoA to carnitine. CPT2 in the inner mitochondrial membrane then converts the carnitine back to long-chain acyl-CoA and transports fatty acids into the mitochondrial matrix [9, 10] . During the b-oxidation process, acetyl-CoA molecules are repeatedly cleaved from the fatty acid within the mitochondrial matrix, and can then enter the mitochondrial tricarboxylic acid cycle ( Fig. 1 ) and the electron transport chain to produce ATP.
Fatty acids and the b-oxidation pathway have been shown to be vital for oocyte and embryo development [11] [12] [13] [14] [15] . Whereas inhibition of b-oxidation during murine oocyte maturation or early cleavage impairs blastocyst and preimplantation embryo development [11, 15] , increase in b-oxidation by supplementation with L-carnitine improves oocyte developmental competence, in vitro follicle growth, fertilization, and blastocyst development [11, 14] .
Thus far, little attention has been paid to the involvement of fatty acids as an energy source for decidualization or lipid metabolism in ESCs. In the present study, we provide evidence that fatty acid b-oxidation is critical for the process of decidualization. We report that the b-oxidation inhibitors etomoxir (EX) and ranolazine (RAN) significantly impaired decidualization of human ESCs (hESCs). Furthermore, simultaneous inhibition of the fatty acid b-oxidation pathway and the PPP more severely blocked decidualization than did inhibition of either pathway alone in both human and murine ESCs. Finally, simultaneous intrauterine delivery of RAN and GlcN reversibly reduced the birth rate in mice.
MATERIALS AND METHODS

Isolation of hESCs and In Vitro Decidualization
Human endometrial tissue was obtained from human endometrial biopsies. Informed consent was obtained from each patient prior to surgery, and protocols were approved by the Human Research Protection Office of Washington University. Uterine tissue was placed in normal saline and transported to the laboratory. Human primary ESCs were isolated as previously described with a few modifications [7, 16] . Briefly, endometrial tissue was minced into 1-mm 3 pieces and digested in Dulbecco modified Eagle medium (DMEM):F12 containing collagenase (2 mg/ml; Invitrogen) and deoxyribonuclease (15 U/ml; Roche) for 30 min at 378C with agitation. After incubation, the solution was passed through a 40-lm sieve, plated, and cultured in DMEM:F12 media supplemented with 10% heat-inactivated charcoal dextran-treated fetal bovine serum and 50 lg/ml penicillin/streptomycin. Human ESCs were then cultured for 12-14 days to get rid of endogenous hormone effects prior to in vitro decidualization. Human telomerase-immortalized ESCs (hESC-Ts) were the generous gift of Dr. Krikun from Yale University [17] . For decidualization of both primary hESCs and hESC-Ts, approximately 2 3 10 5 cells were plated per well in six-well cell culture plates. After reaching 70%-80% confluency, cells were treated with 1 lM medroxyprogesterone-17-acetate (MPA; Sigma) and 0.5 mM N 6 ,2 0 -O-dibutyryladenosine cAMP sodium salt (db-cAMP; Sigma) for 1-9 days (specific to experiment) [7] . Control samples received 0.1% ethanol.
3-[4,5-Dimethylthiazol-2-yl]-2,5-Diphenyltetrazolium Bromide Assay
Cells were seeded in 96-well culture plates at a density of 5 3 10 3 cells/ well. After 1-9 days (specific to experiment) of in vitro decidualization in the presence or absence of chemical inhibitors (EX, GlcN, or RAN), the media were replaced with 110 ll of media containing 0.5 mg/ml 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) labeling reagent. After 4 h of incubation at 378C, 100 ll of 10% SDS/0.01 M HCl solubilization solution was added to each well, and the cells were incubated for another 4 h at 378C. After incubation, absorbance at 570 nm was measured and converted to cell survival percentage as compared to cells decidualized in the absence of inhibitors.
RNA Extraction and Quantitative Real-Time PCR
Cells were lysed with Trizol Reagent (Invitrogen), and total RNA was extracted according to the vendor's specifications. Equal quantities (1 lg) of total RNA were reverse-transcribed by using the Quantitect Reverse Transcription kit (QIAGEN) in a total of 20 ll. Quantitative real-time PCR was performed with SYBR green fluorescence and the 7500 Fast Real-Time PCR System (Applied Biosystems). Each reaction was performed in triplicate and consisted of 25 ng of cDNA, 13 Fast SYBR Green master mix (Applied Biosystems), and 300 nM gene-specific primers. The results were normalized to b-actin or ribosomal protein 36B4 as internal controls in murine or human cells, respectively. Relative gene expression data were calculated by the DDCt method and expressed as fold change relative to decidualized cells. The sequences of primers used for quantitative PCR are listed in supplemental Table  S1 (all Supplemental Data are available online at www.biolreprod.org).
CPT1 Knockdown Expression
Human primary ESCs were infected with CPT1-L short hairpin RNA (shRNA) Lentiviral Particles or control shRNA Lentiviral Particles-A (Santa Cruz Biotechnology). After 2 days, 10 lM puromycin was added for another 2 days to eliminate noninfected cells. The cells were approximately 80% confluent after puromycin elimination, and were then treated with MPA and dbcAMP for 4 days to induce decidualization. Control cells received no hormone supplements. Total RNA was isolated, and gene expression levels were examined by quantitative real-time PCR as described above.
Metabolite Microanalytic Assay
Microanalytic assay was designed to measure pyruvate dehydrogenase (PDH) activity by linking with NAD/NADH. Briefly, cells were seeded in 10-cm Petri dishes and decidualized in the presence or absence of GlcN and RAN, as described above. After 9 days, cells were harvested in cell dissociation solution (Sigma) and lysed by 100 ll enzyme extraction buffer ( TSAI ET AL.
5 mM b-mercaptoethanol, 25% glycerol, and 0.5% Triton X-100). Next, 10 ll of cell extracts was added to 40 ll PDH reagents (62. 5 , 500 lM Na pyruvate, 250 lM CoA, and 500 lM NAD), and incubated at 378C for 5 min, followed by adding 10 ll 0.35 N NaOH and incubation at 608C for 25 min. Then, the 1 ml mixture of 6 N NaOH, 10 mM lmidazole base and 0.01% H 2 O 2 was added and then incubated at 608C for 20 min to enhance NAD-to-NADH reaction [18] . Different concentrations of NAD were added to the reagent tubes simulated as internal standards. The NAD/NADH signal was measured by fluorometry at 340 nm, converted to PDH activity, and normalized with cell counts. Three independent replicates were performed.
Bodipy Immunofluorescence
Approximately 2 3 10 5 hESC-Ts were plated per cover slip within six-well cell culture plates. After reaching 70%-80% confluency, cells were decidualized for 9 days and then fixed in 3% paraformaldehyde for 30 min. Samples were incubated with 1 lg/ml Bodipy 493/503 (Invitrogen) lipophilic dye for neutral lipid for 1 h and counterstained with TOPRO-3 iodide dye (Molecular Probes) for 20 min. All incubations were at room temperature, and the cover slips were washed in PBS between each incubation step and before mounting in VectaShield (Vector Laboratories). Cover slips were put on slides, sealed, and examined with a confocal microscope (Zeiss).
Oil Red O Staining
Human ESC-Ts were plated on cover slips and decidualized for 9 days. Cells were fixed with 40% formalin (Fisher) for 1 min at room temperature, and then stained with filtered oil red O solution (3 mg/ml in 60% isopropanol) for 10 min at room temperature. Cells were then washed with water to remove unbound dye, counterstained with hematoxylin, and mounted with an aqueous mounting medium. Cover slips were put on slides, sealed, and visualized by light microscopy (Nikon Eclipse E800).
Animal Care and Use
All procedures in this study were approved by the Animal Studies Committee at Washington University School of Medicine and conformed to National Institutes of Health guidelines. Female ICR (The Harlan Laboratories) mice 8-9 wk of age were used for the isolation of primary ESCs and in vivo deciduoma induction studies. Female ICR mice 9 wk of age were used for the pellet implantation surgeries.
Isolation of Murine ESCs and In Vitro Decidualization
Murine ESCs were isolated as previously described [5, 7] . ESCs were cultured and decidualized as previously described [8] .
Artificially Induced Deciduoma
Female ICR mice 8-9 wk of age were used to generate deciduomas and were treated as described previously [7] . In brief, mice were ovariectomized, and 2 wk later, they received three daily subcutaneous injections of 100 ng E 2 in 100 ll of sunflower seed oil (Sigma) followed by 2 days of recovery. Next, mice received 3 days of subcutaneous injections of 10 ng of E 2 together with 1 mg of P 4 . At 2 h after the last of the above sensitization injections, sunflower seed oil (100 ll) was injected into the lumen of the right uterine horn, whereas the left noninjected uterine horn served as a control. Mice continued to receive four daily subcutaneous injections of 1 mg of P 4 . For the RAN/GlcN treatment, mice received two daily intraperitoneal injections of 33 ng of RAN together with 250 ng of GlcN in 100 ll of PBS starting on the day the E 2 /P 4 injections were begun, followed by intraluminal injection of RAN/GlcN in 100 ll sunflower seed oil and four daily intraperitoneal injections of RAN/GlcN in 100 ll PBS, until mice were killed. The whole uterus was dissected out and weighed on the day after the last injection.
Histology
Uteri were fixed with 10% neutral buffered formalin solution (Sigma) and embedded in paraffin. Tissue section were cut, stained with oil red O and counterstained with hematoxylin, and visualized by light microscopy (Nikon Eclipse E800).
Pellet Implantation and Hysterectomy
Female ICR mice (9 wk of age) were anesthetized with ketamine and xylene 1 day after pups were delivered. One uterine horn was removed according to a standard hysterectomy procedure to mimic a single uterine model. A sustained-release RAN-containing pellet, together with a sustainedrelease GlcN-containing pellet or two placebo pellets, were implanted into the top of the single remaining uterine horn. Pellets used in this study were 1.5 mm in diameter and released 2 lg of RAN, 3 lg of GlcN, or 15 lg of GlcN over 60 days (Innovative Research of America). Mice were allowed 10 days for recovery in an independent cage and then mated with ICR males. The number of pups per litter was recorded until two litters after the 60-day pellet release period. Pup number was counted as zero if no pup delivered within the 60-day pellet-active and postpellet periods, because the gestation period for ICR mice ranges from 19 to 21 days.
Statistical Analyses
All results are expressed as mean 6 SEM. Statistical comparisons between control values and experimental values were made by Student t-test or ANOVA with Bonferroni multiple comparison test (PRISM program; GraphPad). Significance was defined as P , 0.05.
RESULTS
The b-Oxidation Pathway Is Important for In Vitro Decidualization of hESCs
To determine whether fatty acid b-oxidation is important for decidualization of ESCs, we treated an hESC-T line with the CPT1 inhibitor EX [19] and assessed decidualization by monitoring the mRNA levels of four markers, prolactin (PRL), insulin-like growth factor binding protein 1 (IGFBP1), somatostatin (SMST), and interleukin-15 (IL-15) [4, [20] [21] [22] . Whereas expression of these genes was low or undetectable before decidualization and greatly increased after exposure to decidualizing conditions (MPA and db-cAMP; described in Materials and Methods), we observed a dose-dependent reduction of expression of these genes when cells were decidualized in the presence of EX (Fig. 2, A-D) . The expression levels of these markers in cells in the presence of EX were already lower than in cells in the decidualization media alone by Day 3 for IL-15 and SMST and Day 6 for PRL and IGFBP1 of in vitro culture, and this persisted throughout the full 9 days of decidualization (Fig. 2, A-D) . Notably, mRNA levels of these genes in decidualized cells exposed to 50 lM EX were drastically decreased, remaining at levels nearly as low as in nondecidualized cells.
We next sought to determine whether EX had similar effects on primary ESCs. Human primary ESCs were isolated from uteri after biopsies and then cultured in decidualization media, with or without EX (see Materials and Methods for details). As described above for hESC-Ts, expression of PRL, IGFBP1, IL-15, and SMST decreased in a dose-dependent manner in the presence of EX. However, gene expression in primary cells was not as strongly affected as in hESC-Ts; expression of markers in the presence of 50 lM EX was higher than in nondecidualized cells (Fig. 2E) .
To further confirm the requirement for b-oxidation in decidualization, we wanted to knock down CPT1 gene expression in hESCs. Three isoforms of CPT1 have been reported: CPT1A is expressed nearly ubiquitously, CPT1B is expressed in heart and skeletal muscle cells, and CPT1C is brain specific [23, 24] . Because quantitative RT-PCR revealed that CPT1A, but not CPT1B, is highly expressed in hESCs (data not shown), we infected human primary ESCs with lentiviral particles encoding either a CPT1A-specific shRNA or a scrambled shRNA as a control. In both nondecidualizing and decidualizing conditions, cells infected with the CPT1A- 
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specific shRNA expressed six-fold less CPT1A mRNA than cells infected with the scrambled shRNA (Fig. 2F) . Cells in which CPT1 was knocked down also exhibited a significant diminution of expression levels of decidual markers after 4 days in decidualization media (Fig. 2F) . Taken together, these results indicate that fatty acid b-oxidation is important for proper hESC decidualization in vitro.
EX Causes Lipid Droplet Accumulation and Cell Death in hESC-Ts
EX inhibits CPT1 activity and thus b-oxidation; as a result, EX treatment causes lipid accumulation in the livers of rats [25] . We used oil red O and Bodipy staining of lipids to determine whether or not this was the case in ESCs. We observed a significant increase in the number of cytoplasmic lipid droplets in hESC-Ts after 9 days of EX exposure (Fig. 3 , A-D and F-I). Because lipid accumulation can be harmful for cells, hESC-Ts were decidualized with or without EX, and the MTT assay was used to determine cell viability. Relative to mock-treated cells, decidualizing cells exposed to 25 and 50 lM EX had reduced viability by Day 9 (81% and 73%, respectively; data not shown). Viability of cells exposed to 50 lM EX dramatically dropped to 51% by Day 12 (Fig. 4) , suggesting that higher dosages of EX could be damaging for hESCs.
RAN Inhibits hESC Decidualization In Vitro
Because EX was toxic to cells, and the reduced cell viability from EX exposure may affect the expression profiling of the decidual marker genes, we next examined the effect of RAN, a partial fatty acid b-oxidation inhibitor (Fig. 1) [26] , on viability of hESCs. As shown in Figure 4 , 12-day exposure to 100 lM RAN had no significant effect on cell viability, suggesting that decidualizing hESC-Ts could tolerate RAN. As with EX, 3-day exposure to RAN reduced the mRNA levels of decidual markers (Fig. 5A) , further confirming that b-oxidation is important for hESC decidualization. However, the inhibitory effect of RAN was gradually compromised during later stages of decidualization (Fig. 5, B and C) , implying that feedback mechanisms can gradually overcome the inhibitory effects of RAN on decidualization.
RAN-Treated ESCs Compensate by Increasing Glucose Utilization
Previous studies have shown that RAN indirectly activates PDH, which catalyzes pyruvate to acetyl-CoA, by reducing the acetyl-CoA:CoA ratio [27, 28] . To examine whether this occurs after exposure to RAN during in vitro decidualization, we performed a metabolite microanalytic assay to measure PDH activity in hESC-Ts. As shown in Figure 6A , PDH activity was 36% higher in RAN-treated cells than in control cells after 9 days of decidualization. Because PDH activity is required for glucose metabolism, this result suggests that blockade of b-oxidation by RAN may result in activation of glucose utilization in hESC-Ts. Thus, we examined expression of GLUT1 in cells exposed to RAN. Consistent with previous findings that GLUT1 mRNA expression level was up-regulated during the process of decidualization [5] , we observed a significant increase of GLUT1 mRNA expression during the 9-day decidualization period (Fig. 6, B-D) . Although the level of GLUT1 mRNA expression in cells treated with 100 lM RAN was reduced at Day 3, it was at similar levels as observed in decidualizing cells at Days 6 and 9. This reduction of GLUT1 expression at Day 3 and later increase in expression in RANtreated cells mirrors our observation that decidualization marker expression was inhibited at Day 3, but gradually increased in cells exposed to RAN (Fig. 5) . Taken together, these results suggest that RAN triggers a compensatory upregulation of GLUT1 expression and glucose utilization that compromise the inhibitory effects of RAN during decidualization.
Simultaneous Inhibition of the b-Oxidation Pathway and PPP Inhibits Decidualization of Human ESCs
Glucose utilization has been reported to be important for decidualization [4, 5] , and we have shown that inhibition of the PPP with GlcN can inhibit decidualization of human and mouse ESCs [8] . We thus wondered whether simultaneous inhibition of the b-oxidation pathway and PPP would be tolerated by ESCs and impair decidualization. We first performed viability tests and found that treatment with inhibitors reduced the proliferation of nondecidualizing hESC-Ts (Supplemental Fig. S1 ; all Supplemental Data are available online at www.biolreprod.org); however, cells that were mock treated, those that were exposed to GlcN alone, and those that were exposed to a combination of RAN plus GlcN had similar viability after the 12-day decidualization period (Fig. 4) . Furthermore, RAN/GlcN exposure did not cause dramatic lipid droplet accumulation in ESC-Ts (Fig. 3 , E and J). Next, we assessed decidualization by monitoring the levels of mRNA expression of decidual markers after 9 days of in vitro decidualization. Whereas PRL, IGFBP1, IL-15, and SMST were greatly induced during in vitro decidualization, expression levels of these markers decreased in a RAN/GlcN dosedependent manner (Fig. 7A) . We also investigated the effect of the RAN/GlcN mixture on decidualization of human primary ESCs to determine whether these effects were specific to ESCTs. The human primary ESCs were obtained from human endometrial biopsies, as outlined in Materials and Methods, and cultured in decidualization media, with or without RAN/ GlcN mixtures, for 9 days. As described above for hESC-Ts, mRNA levels of decidual markers also decreased upon exposure to RAN plus GlcN (Fig. 7B) . Furthermore, the inhibitory effects of the RAN/GlcN mixture on decidualization were significantly stronger than those of RAN (Fig. 5) or GlcN alone [8] . 
TSAI ET AL.
For example, whereas 100 lM RAN inhibited expression of IL-15 by 32.1% on Day 9 of decidualization of hESC-Ts (Fig.  5C) , and 2.5 mM GlcN inhibited IL-15 expression by 24.8% [8] , 100 lM RAN plus 2.5 mM GlcN inhibited expression of IL-15 by 44.5% (P , 0.05 and P , 0.001, respectively). This additive effect strongly indicates that the b-oxidation pathway and PPP are each independently important for ESC decidualization.
Simultaneous Inhibition of the b-Oxidation Pathway and PPP Inhibits Decidualization of Murine ESCs Both In Vitro and In Vivo
We wanted to determine whether the RAN plus GlcN combination could inhibit decidualization in vivo. Thus we first asked whether it could inhibit decidualization of murine ESCs in vitro. Primary ESCs were isolated from the gravid uterus at 4 days postcoitus and cultured for 3 days in decidualization media. The mRNA expression of the murine decidual marker Prp was decreased in a dose-dependent manner upon exposure to RAN plus GlcN (Fig. 8A) . To examine whether the combination of RAN plus GlcN could inhibit decidualization in vivo, we examined their effects in an 
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oil-induced deciduoma model [7, 8] . Female mice (8-9 wk of age) were ovariectomized and treated with a regimen of E 2 and P 4 to sensitize the uterus to induced decidualization. One uterine horn of each female was mechanically stimulated by oil injection, and the unstimulated horn served as an internal control. Whereas the control uteri exhibited a robust decidual response (increasing in weight by approximate 24.6 fold), the uterine horns of RAN/GlcN-treated mice revealed weak or no deciduoma formation (increasing in weight by only 5.5 fold; Fig. 8, B and C) . Furthermore, morphological examination of uterine cross-section revealed that enlarged and rounded decidual cells were prominent in the oil-stimulated control uterus (Fig. 8D) . In contrast, although the upper parts of the stimulated horns from RAN/GlcN-treated mice were thicker than the rest of the stimulated horns, cross-sections from the upper uterine horns revealed that the size of the stromal compartment was still smaller than those of control mice. Additionally, oil red O staining reveled that there was no dramatic lipid droplet accumulation in ESCs from RAN/GlcNtreated mice (Fig. 8D) , consistent with the observations of RAN/GlcN exposure in ESC-Ts (Fig. 3) . Taken together, these results clearly demonstrate that RAN/GlcN treatment inhibits murine ESC decidualization.
Intrauterine RAN/GlcN Decreases Birth Rate in Mice
Several studies have shown that failure of decidualization results in prevention of pregnancy [29, 30] , and our previous study demonstrated that placement of GlcN pellets in the uterus decreased the birth rate in mice [8] . To examine the in vivo effect on birth rates of simultaneously blocking the b-oxidation pathway and PPP, we used this same pellet-implantation strategy. To mimic the single reproductive tract found in humans, one uterine horn was hysterectomized, and timerelease RAN and GlcN pellets were implanted in the remaining horn. The litter sizes from pellet-containing females were recorded both during the 60-day pellet-active period and in the postpellet period. In mice implanted with placebo pellets, litters were about half the size that they were before hysterectomy (5.75 6 0.64 vs. 12.33 6 0.61 pups per litter), as expected, and the litter sizes were similar between the pellet-active and postpellet periods (5.75 6 0.64 and 4.83 6 0.54 pups) (Fig. 9 ). This confirms our previous observation [8] that there is a fairly equal implantation rate in both horns and that pellet implantation per se does not interfere with fertility. In contrast to the placebo-implanted mice, those that received intrauterine RAN/GlcN pellets delivered significantly fewer live pups per litter during the pellet-active period (2 lg RAN/15 lg GlcN, 2.41 6 0.65 pups; 2 lg RAN/3 lg GlcN, 3.41 6 0.70 pups; placebo, 5.75 6 0.64 pups; Fig. 9 ). Furthermore, the litter size from females with 2 lg RAN/15 lg GlcN pellet implantation was smaller than that from females with 15 lg GlcN pellet (2.41 and 2.75 pups, respectively), although the differences were not significant. The pups that were born exhibited no birth defects in gross morphological assessments. After the 60-day pellet release period, the litter sizes delivered by RAN/GlcN and placebo pellet-implanted mice were similar, suggesting that the RAN/GlcN pellets did not cause long-term fertility sequelae.
DISCUSSION
Here we present in vitro evidence in human and in vitro and in vivo evidence in mouse that decidualization requires activity of the fatty acid b-oxidation pathway. Our data support several other lines of evidence that fatty acids are an important energy source in the decidualizing endometrium. First, although the decidua is known to store lipid droplets and glycogen [31, 32] , fatty acids generate more ATP on an energy-per-gram basis than is produced by carbohydrates or protein. Second, increasing amounts of phospholipids have been observed in the stroma immediately surrounding the implanting embryo after Day 5 of pregnancy in the mouse [31, 33] , and boxidation is important for functional lipid synthesis [34] . Third, expression of fatty acid synthase, the enzyme required for de novo fatty acid synthesis, declines during the early to midsecretory phase, but reappears at the time of ESC differentiation in human endometrium [35] . Similarly, fatty acid-binding protein 4 is highly expressed in mouse decidua and during in vitro decidualization of murine ESCs [36] . Thus, it is not surprising that blocking the fatty acid b-oxidation pathway impairs decidualization.
By what mechanism does blocking the fatty acid boxidation pathway impair decidualization? A strong possibility is that EX and RAN inhibit decidualization by reducing phospholipid biosynthesis. A second possibility is suggested by the fact that extensive proliferation of stromal cells surrounding the implanting blastocyst is one of the hallmark events of decidualization [37] . We observed, both in vitro and in vivo, that proliferation of ESCs was attenuated upon exposure to RAN or RAN plus GlcN. A third mechanism by which decidualization could be inhibited is by increased apoptosis of the ESCs. In this study, EX exhibited stronger inhibitory effect on decidualization than RAN in hESCs. It is possible that EX generates a certain level of cytotoxicity that affects the expression profiling of decidual markers, whereas RAN is tolerated by hESCs. Alternatively, a higher dosage of RAN may lead to a stronger inhibitory effect on decidualization as EX. We can't exclude this possibility of apoptosis for EX, but our data indicate that RAN was well tolerated by the ESCs during the culture period. Thus, we argue that increased apoptosis is unlikely to explain the inhibition of decidualization that we observed.
Which energy source, fatty acids or carbohydrates, is used predominantly for energy production in vivo may vary under diverse physiologic, nutritional, and medical conditions. Inhibition of b-oxidation, and reciprocal activation of glucose metabolism, by EX and RAN have yielded therapeutic benefits for the treatments of heart failure or chronic stable angina [38] [39] [40] . In these cases, the partial b-oxidation inhibitor RAN activates PDH and leads to improvement of myocardial function and less oxygen requirement during ischemia [41, 42] . Consistent with this, we observed that RAN significantly increased PDH activity and GLUT1 mRNA expression, suggesting that RAN also enhances glucose utilization in hESCs. The GLUTs determine the efficiency of glucose uptake by cells. GLUT1 is the most abundant and critical GLUT in murine and hESCs, and its expression increases in murine ESCs during pregnancy as well as in hESCs during in vitro decidualization [4, 5] . If glucose uptake is reduced by knocking down GLUT1 expression, dramatically reduced decidualization occurs [5] . Therefore, the increase of glucose utilization triggered by RAN exposure may explain why we observed a recovery of expression of decidualization markers in hESCs after several days.
The products of fatty acid b-oxidation include reduced form of flavin adenine dinucleotide (FADH2), NADH, acyl-CoA, The horn that received a physical stimulus to induce deciduoma formation is on the right, and the unstimulated internal control horn is on the left. C) The mass of deciduoma and control uterine horns was quantified for control and RAN/GlcN-treated mice. Values are the and the final product, acetyl-CoA, which enters the tricarboxylic acid cycle for energy production. Because sodium pyruvate is actively transported into cells and converted to acetyl-CoA [43, 44] , we attempted to rescue ESC decidualization in RAN-or EX-treated cells by supplementing the media with sodium pyruvate (which is commonly used in cell culture), but this was unsuccessful (data not shown). This finding suggests that FAHD2, NADH, or acyl-CoA may contribute to the decidual response. Alternatively, exogenous pyruvate administration could accelerate glycolysis or alter the redox balance in cells, and thus impair ESC decidualization [45] .
Endometrial receptivity is required for pregnancy, and is driven by hormones during the menstrual cycle [1] . One mechanism by which contraception may work is to prevent the endometrium from becoming receptive for embryo implantation. We previously suggested that GlcN could be used as a reversible, nonhormonal contraceptive method [8] . Because RAN plus GlcN more strongly inhibited in vitro decidualization than did GlcN alone, we tested this combination in the in vivo pellet-implantation model. Although simultaneous uterine implantation of RAN and GlcN pellets greatly reduced birth rate in mice, it did not provide complete contraception. One complication of these experiments is that the murine uterine horn is a long tube shape, so embryos may have implanted far away from the RAN/GlcN pellets. Another complication is that, although the dosages of the pellets used in this study were converted from the concentrations of inhibitors used in vitro, it is difficult to compare dosages administered by these two routes. The dosages of the pellets we used (0.001 lg/g/day for RAN and 0.008 lg/g/day for GlcN) are far below the standard oral dosages in human (1000-2000 mg/day RAN and 1500 mg/ day GlcN) and the LD 50 (lethal dose, 50%) of oral dosages in mouse (RAN, 300 lg/g body weight; GlcN, 8 mg/g). Thus, higher doses are probably safe to use and may be more effective at preventing pregnancy. Importantly, the litter sizes of the mice implanted with RAN/GlcN pellets fully recovered during the postpellet period, implying that RAN/GlcN pellets are not likely to cause adverse whole-body effects.
There is a long period of gestation between the time of ovulation and fetus delivery; thus, we cannot rule out the possibility that RAN/GlcN affected other aspects of fertility, although there is no evidence to suggest that RAN affects the ovary and embryo development. Nevertheless, previous reports have observed that oocyte and blastocyst development are impaired by GlcN exposure during embryo culture or in vitro maturation [46, 47] . Mice injected intraperitoneally with 20 or 400 mg/kg GlcN on 3-6 days before and 1 day after mating have been reported to be associated with increased embryo absorption rate [48] , and mice that received 40 mg GlcN subcutaneous injection on Day 7.5 pregnancy have also been shown to be associated with increased incidence of neural tube defects [49] . On the other hand, we performed uterine fat pad injection, which demonstrated significantly fewer embryo implantation sites of one uterine horn with RAN/GlcN injection than the other, noninjected uterine horn, whereas control mice exhibited a similar number of implantation sites in both the horn injected with vehicle and the noninjected horn. (Supplemental Fig. S2 and Supplemental Materials and Methods). This suggests that pup number reduction mainly resulted from decidualization defect caused by RAN/GlcN.
The pellet-implantation experiment was designed to mimic the human contraceptive intrauterine devices (IUDs). Currently, the copper IUD is the only long-acting, nonhormonal contraceptive method [50] , and more options for nonhormonal contraceptives are considered necessary for patients unable to tolerate hormonal methods [51] . Our findings support the potential for development of RAN/GlcN as a reversible, nonhormonal contraceptive that functions by a novel mechanism-altering cellular metabolism. Further exploration of the development and testing of a RAN/GlcN IUD in a single uterine horn model, such as primates, is warranted.
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